ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EnClear Spins out of QurAlis
americanpharmaceuticalreview
December 29, 2018EnClear Therapies has spun-out from QurAlis Corporation, a biotech company focused on developing precision therapeutics for ALS and other neurological diseases. EnClear’s mission is to halt the progression of .... -
QurAlis Launches with Seed Funding from MPH, Amgen and Alexandria Venture
americanpharmaceuticalreview
April 09, 2018QurAlis announced the addition of biotech investors MP Healthcare Venture Management (MPH), Amgen Ventures, and Alexandria Venture Investments, who have joined to cure Amyotrophic Lateral Sclerosis (ALS)
Pharma Sources Insight January 2025
